KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Cash from Operations (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Cash from Operations data on record, last reported at 517400000.0 in Q4 2025.

  • For Q4 2025, Cash from Operations rose 2.19% year-over-year to 517400000.0; the TTM value through Dec 2025 reached 1697100000.0, up 13.19%, while the annual FY2025 figure was 1697100000.0, 13.19% up from the prior year.
  • Cash from Operations reached 517400000.0 in Q4 2025 per ZBH's latest filing, up from 418700000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 588400000.0 in Q4 2023 and bottomed at 223500000.0 in Q1 2021.
  • Average Cash from Operations over 5 years is 376930000.0, with a median of 373800000.0 recorded in 2024.
  • The widest YoY moves for Cash from Operations: up 893.56% in 2021, down 50.43% in 2021.
  • A 5-year view of Cash from Operations shows it stood at 337600000.0 in 2021, then dropped by 27.67% to 244200000.0 in 2022, then surged by 140.95% to 588400000.0 in 2023, then fell by 13.95% to 506300000.0 in 2024, then rose by 2.19% to 517400000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 517400000.0 in Q4 2025, 418700000.0 in Q3 2025, and 378200000.0 in Q2 2025.